- Home
- SYBT vs NKTR Comparison
SYBT vs NKTR Comparison
Compare SYBT & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYBT | NKTR |
|---|---|---|
| Founded | 1904 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2009 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SYBT | NKTR |
|---|---|---|
| Price | $69.01 | $70.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $76.00 | ★ $146.67 |
| AVG Volume (30 Days) | 119.3K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | ★ 22.11 | N/A |
| EPS | ★ 1.24 | N/A |
| Revenue | $23,406,000.00 | ★ $307,711,000.00 |
| Revenue This Year | $17.31 | N/A |
| Revenue Next Year | $9.32 | N/A |
| P/E Ratio | $56.43 | ★ N/A |
| Revenue Growth | 3.37 | ★ 86.00 |
| 52 Week Low | $61.51 | $0.61 |
| 52 Week High | $83.83 | $109.00 |
Technical Indicators
Market Signals| Indicator | SYBT | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 32.56 |
| Support Level | $67.32 | $64.30 |
| Resistance Level | $71.41 | $76.67 |
| Average True Range (ATR) | 1.78 | 3.65 |
| MACD | -0.49 | -2.19 |
| Stochastic Oscillator | 8.39 | 5.58 |
Price Performance
Historical ComparisonAbout SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.